Good Price Powder Voglibose Cas:83480-29-9 CAS NO.83480-29-9

1.high quality:

quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.

2.reasonable price:

we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.

3.low moq:

no worry about the low moq, our moq is 1 gram or even lower.

4.good service.

fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.

5. fast shipping and secure courier.

we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.

[English name] Voglibose 
[Molecular formula] C10H21NO7
[Molecular weight]267.278
[CAS Number] 83480-29-9
[Product resource] 
[Specification] 98%
[Product properties]Voglibose, an alpha-glucosidase inhibitor, is a synthetic compound with potent and enduring therapeutic efficacies against disorders of sensory, motor and autonomic nerve systems due to diabetes mellitus. The drug was approved in Japan in 1994 for the treatment of diabetes, and it is under further investigation by Takeda for the treatment of impaired glucose tolerance. Alpha glucosidase inhibitors are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by
preventing the digestion of complex carbohydrates (such asstarch). Complex carbohydrates are normally converted into simple sugars (monosaccharides) which can be absorbed through the intestine. Hence, alpha-glucosidase inhibitors reduce the impact of complex carbohydrates on blood sugar.
[Application scope] Acarbose is an anti-diabetic drug used to treat type 2 diabetes mellitus and, in some countries, prediabetes. It is sold in Europe under the brand name Glucobay (Bayer AG), in North America as Precose (Bayer Pharmaceuticals), and in Canada as Prandase (Bayer AG). It is an inhibitor of alpha glucosidase, an enteric enzyme that releases glucose from larger carbohydrates

Voglibose is orally active Maltase-glucoamylase (α-glucosidase) inhibitor (IC50 values are 3.9 and 6.4 nM at sucrase and maltase respectively). It increases glucagon-like peptide 1 (GLP-1) secretion and also decreases food consumption in ob/obmice. Voglibose reduces plasma concentrations of glucose, triglycerides and insulin in Wistar fatty rats. Additionally, voglibose exhibits antidiabetic and antiobesity activity in vivo.